FinTrust Capital Advisors’s Calithera Biosciences, Inc CALA Stock Holding History

FinTrust Capital Advisors’s Portfolio CALA Stock Details CALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,201	Closed	-$3.92K	–	1384
2023 Q2	$3.92K	Hold	1,201	–	–	﹤0.01%	907
2023 Q1	$3.92K	Hold	1,201	–	–	﹤0.01%	901
2022 Q4	$3.92K	Hold	1,201	–	–	﹤0.01%	898
2022 Q3	$3K	Hold	1,201	–	–	﹤0.01%	1108
2022 Q2	$4K	Sell	1,201 -1	-0.1%	-$5	﹤0.01%	1076
2022 Q1	$10K	Hold	1,202	–	–	﹤0.01%	961
2021 Q4	$16K	Buy	1,202 +545	+83%	+$13.7K	﹤0.01%	814
2021 Q3	$29K	Buy	657 +375	+133%	+$16.2K	0.01%	652
2021 Q2	$12K	Hold	282	–	–	﹤0.01%	902
2021 Q1	$14K	Buy	+282	New	+$16.4K	﹤0.01%	818

Other funds holding CALA

CAS

Coppell Advisory Solutions Coppell, Texas $1.21B AUM 20.39% 1-Year Est. Return

FinTrust Capital Advisors's CALA Position: Q3 2023 in Review

FinTrust Capital Advisors sold out of Calithera Biosciences, Inc (CALA) in Q3 2023, closing a stake of 1,201 shares — an estimated $3.92K sold.

FinTrust Capital Advisors first reported a position in CALA in Q1 2021 and held it in 10 quarters. The position peaked at $29K in Q3 2021. 1 fund tracked by Wall St. Rank holds CALA as of Q3 2023.

FinTrust Capital Advisors reported no remaining Calithera Biosciences, Inc position as of Q3 2023 after selling out during the quarter.
FinTrust Capital Advisors sold 1,201 Calithera Biosciences, Inc shares in Q3 2023, an estimated $3.92K.
FinTrust Capital Advisors first reported a position in Calithera Biosciences, Inc in Q1 2021 and held it in 10 quarters.
FinTrust Capital Advisors's Calithera Biosciences, Inc position peaked at $29K in Q3 2021.
1 fund tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q3 2023.

Based on FinTrust Capital Advisors's 13F filing for Q3 2023, filed 24 Oct 2023.